Insider trades
Seshadri Neervannan, COO of Tarsus Pharmaceuticals TARS, has filed 0 purchases and 15 sales on the open market. Over the past 12 months that comes to a net sale of $1.6M. The latest trade was on 03/20.
Seshadri Neervannan
COO
- Company
- Tarsus Pharmaceuticals TARS
- First filing
- 23/03/10
- Trades
- 39 trades
- Buys / sales
- 0 / 15
- 12-month net buying
- −$1.6M
- Last trade
- 03/20
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
| Open-market sale10b5-1 plan | 03/20 | 03/24 | 2,989 sh | $66.75 | $199,515.75 | −3.5% | |
TARS | Open-market sale | 03/17–03/19 | 03/19 | 11,324 sh3 trades | $68.21avg. | $772,443.6 | −11.7% |
| Open-market sale10b5-1 plan | 03/04 | 03/05 | 8,366 sh | $76.67 | $641,421.22 | −10.6% | |
TARS | Open-market sale | 25/03/18–25/03/20 | 25/03/20 | 7,583 sh3 trades | $47.89avg. | $363,141.5 | −8.7% |
| Open-market sale | 24/03/18 | 24/03/19 | 4,879 sh | $30.60 | $149,297.4 | −7.0% | |
TARS | Open-market sale | 23/03/21–23/03/23 | 23/03/23 | 1,141 sh3 trades | $12.55avg. | $14,324.14 | −2.0% |
TARS | Open-market sale | 23/03/17–23/03/20 | 23/03/21 | 740 sh2 trades | $12.94avg. | $9,572.6 | −1.3% |
| Open-market sale | 23/03/16 | 23/03/17 | 357 sh | $13.43 | $4,794.51 | −0.6% |